Search This Blog

Sunday, August 2, 2020

162



This was originally published here, in French (link).
We provide this translation for your convenience. Practical aspects may differ where you live.




4/7 in Italy! It's coming, it's coming...

By Charles-Edouard!

Very pertinent question, asked here:
What could be more natural than to think about it! When you see success rates of almost 100% in 4/7 for others, and a prolonged efficiency for yourself, you would like to think that limiting yourself to 5/7 would have been a missed opportunity. As it is iterative and Darwinian, the next increment is 3/7, it is obvious. This is not validated by a large clinical trial... So what??? it has not been invalidated either. If you don't even look for it, you can't find it!

The experimental method is described in FASEB-1: make sure of the good susceptibility of HIS virus (something that must have been done before initiating 4/7, so normally it's good), make sure of the efficacy at 4/7, don't try it under Isentress, Genvoya, Kaletra (but who still takes that?) monitor at the beginning by CV 1 month, 2 months, 4 months, 6 months (at the beginning only), and that's all! BIOLOGICAL follow-up necessary. The medical follow-up? Well... For the comfort of the mind? Maybe ? And still ... In any case, the medical follow-up in 3/7, did exist (100% success rate, subtracting the risk combos), and, in practice, it disappeared with Leibowitch...

What does the ANRS tell you? It could not be clearer: ' Get on with it
'...

A new publication in 4/7


This publication comes from Italy. We had distributed our biblio to various clinicians. Including them... Did it help? I don't know. We can see that French works are abundantly cited (ICCARE, Leibowitch, Calin, ANRS-4D, Quatuor). Normal, there are not many others (Breather, in 5/7, at most...). The results are the same: 100% success, a few dropouts... It's like usual... Nothing new... And the nothing new is reassuring!

The very interesting discussion is in the body of the text. That's why I made a translation in french, in extenso. You have to read it. There is a vibrant tribute to ICCARRE, despite a small inaccuracy: Leibowitch et al. published in 2010 (FASEB-1 and 2015 FASEB-2), BREATHER was published in 2016, so Leibowitch is earlier, not the other way around...


The dosages... They are instructive!


They made 4 dosages per patient... It is instructive, because as in ANRS 4-D, there are cheaters, and it shows! There seems to be 1 or 2 who take more, but mostly a dozen, or a third, who take less. And it works just as well! It shows us the way: 4/7 is good to start... It's a start... And, after a while, you have to grow up

The threshold dose is a joke!


The threshold dose is determined by the failures when introducing the molecule in a new therapeutic scheme. Never in the long term, never... I challenge you to find a threshold dose at T plus 1 year that is equal to that seen in the short term. The good example is Nevirapine, with its dose-dependent failures at less than 6 months(thanks to poor tolerability in some), but no failure beyond 8 months. No failures: no threshold.

The authors discuss here the doses observed after 3 days of interruption (but perhaps more, the patients were just doing their own thing), and we are successful even at values well below the IC90. Note that the 'official' therapeutic dose is 3 times IC90 for Rilpivirine, while it is 15 times IC90 for the more effective Dolutegravir. Look for the mistake...

The Eclipse exists: we see it, so what does the threshold dose mean? Moreover, in the long term, we don't know how to determine it. In the stable phase, it's just a flan!

Can do better...


I like this kind of publication: it is an obvious progress in the percolation of ICCARRE at the international level. This publication is in addition to the others. This poses 2 problems:

- as long as one perceives that the Eclipse is only a few days long, for everyone(vision of the 2000s), it is quite logical to consider the results of others for a reflection on oneself. Now that we have Eclipses that are both longer and more dispersed, these tests on others, on non-identical viruses, no longer make any sense!

- The tests accumulate ad nauseam. Medical Darwinism obliges, it is only a question of time that we pass to 3/7... And what a waste of time! Obviously, if 4/7 is as 'good' as 7/7, it is no less 'bad'.

The 'enemy' of yesteryear was 7/7(will there still be people to practice it in a few years?). It has fallen. The new 'enemy' is the 4/7: it will necessarily fall one day...

In the news


- Satoshi Omura, Japanese Nobel Prize winner, presents I*T as a treatment against C*D: no doubt, a Nobel Prize is no match for 'fax checkers' without the slightest scientific background. It should be noted thatin vitro I*T is as effective on Omega as on the others...

- Before/After critical analysis of the pasteurian 'predictions', it's here, and it's scouring! (it's good too...)

- Very well documented article by Helene Bannoun: The origin of the Covid-19 virus

- Very interesting Evaluation of the methodological methodological practices implemented in Pfizer trials, by Christine COTTON

- Genetic Forcing, Self-Disseminating Vaccines, Chimeric Viruses... The sorcerers' apprentices of the genome by our excellent Bruno Canard, Étienne Decroly Jacques Van Helden (it's not free, but if you ask nicely...)

Pieces of Anthology


- The virus has not mutated,' says Professor Karine Lacombe on RTL (at 4 min 50 sec): To be enjoyed in moderation!

- Typhus, a little history on Science.org:

The French genius


Today is Saint Darwin's day! It was Lamarck who discovered Evolution. Darwin, the Evolution under pressure from Selection. This is still relevant, even if many advances have been made since then. Our French genius is Montagnier, who died on February 8.
If he had not set up the Pasteurian Laboratory on Oncoviruses, there would not have been the very lucrative patent, there would probably not have been Barré Sinoussi or Schermann at the head of this world competition. There would have been a genius, but not French...

We don't care about the rest, the squabbles, the greatness and the smallness. Read again Darwin, Descartes or Newton, it's not all rosy either; they also said some bullshit with no equal; history will sort it out.

The fact remains that for us, Montagnier was the beacon of a whole generation! In fact, I am interested in 2 concepts that he exposed:

- DNA does not integrate randomly anywhere (so depending on where it is integrated, it will be more or less active)

- silencing(passive reservoir) is a reasonable therapeutic goal(as for tuberculosis)

We will come back to this, it is inevitable, since it is our salvation...

Feel free to comment, like, share and use

Turn off the TV and don't be fooled by Pharisee venality

Saturday, August 1, 2020

161



This was originally published here, in French (link).
We provide this translation for your convenience. Practical aspects may differ where you live.




Leibowitch on television


In an ancient post JCM declares (whom I thank, by the way):



The video 'Leibowitch chez Drucker (Vivement Dimanche)' has disappeared from YouTube (like almost everything that remains of Leibowitch as a testimony Video). I am working on archiving copies. I have the video, but I don't know where I found it. There is an audio track (which is more than enough), which you can listen to from the Valas website, here. I keep a copy, so let me know if the link disappears.

Michel Drucker:
We are going to welcome a great researcher who teaches at the Raymond-Poincaré hospital in Garches, an AIDS specialist... He was one of the pioneers of the discovery of the virus, I ask you to welcome Doctor Jacques Leibowitch...
You wanted him to be there because the way to treat yourself has changed...

Josiane Balasko: I have a friend who simply told me that Jacques was doing a test protocol on a hundred patients:
Instead of taking a lot of medication every day, people with HIV are taking much less, making their lives easier and more comfortable.

Michel Drucker: You invented triple therapy in the mid-1990s, and for the past 10 years you have been leading a project called Icare. Intermittent, short-cycle antiretrovirals remain effective, which means that you are in the process of demonstrating that it is possible to lighten the treatment while maintaining its effectiveness...

J. Leibowitch: It is possible to go a certain number of days without medication without the virus returning, i.e. after an effective attack treatment, conditions are such in the patient's body that the virus has difficulty in rebounding, a viral eclipse aka viral latency time that allows us to space out the antiretroviral bombardments.

Michel Drucker: So far, triple therapy is a lot of pills 7 days a week...

J. Leibowitch: The established rule, which I have a hard time getting the invention to work against, is that it's 7 days a week, otherwise you're going to hell.

Michel Drucker: Now it's between 4 times and 1 time a week...

J. Leibowitch: Some treatments can be stopped for up to 6 days a week without the virus having had time to rebound.

Josiane Balasko: What needs to be done to make this a widespread thing?

J. Leibowitch: The rule has to be changed. It's a question of psychology, of physiology, that's a lot less chemical medication...

Michel Drucker: However, we should not think that we can do this in a wild way...

J. Leibowitch: Self-prescribing is forbidden, it has to be driven by a doctor, and until now, doctors don't do it because the rule has not been changed, that's why I'm happy to be here to present the Iccarre project and the good news, which is the reduction from 40% to 85% of the drugs for those who have to take them for life.

Josiane Balasko: I will read an excerpt from a letter from one of his patients: I am 49 years old, I am HIV positive, today I testify to be heard. There are a few hundred of us patients who take triple therapy between 1 and 3 times a week instead of the 7 days a week recommended by the medical profession: for my part, I am at 3 days a week and everything is fine.
In addition, it is time to say that HIV-positive people on treatment do not infect their partners, i.e. they can have unprotected sex without transmitting the virus.
AIDS DOES NOT PASS THROUGH YOU BECAUSE I AM TREATED ...

Michel Drucker: This means that with these simplified procedures, HIV-positive patients under care are no longer transmitting the virus... Do you have trouble convincing your colleagues?

J. Leibowitch: Yes, because it was established the hard way, over the last 15 years where the marks were taken under difficult conditions - it was more the virus that was winning; so a rule was set up defensively, and to change it, the HIV-positive people have to demand it.
The rights of the HIV positive patient to be properly treated, the right to the right dosage, it will not just come to you, you have to ask for it, and I had a lot of trouble to get to you, and I thank the host and this patient.

Michel Drucker: So, it is a question of adjusting the antiviral doses to the strict minimum necessary and sufficient...

J. Leibowitch: Yes, this is the deontological medical rule, it is to adjust the treatments to what is necessary.

Josiane Balasko: You think that consuming less medication will piss off the laboratories?

J. Leibowitch: Let's not attack the laboratories, for the moment, it is the barons of the pulpit who manage the situation and they have a lot of trouble accepting that this pacifying and liberating revolution comes from them.
The good news is that we will be able to reduce from 40 to 85% when we change the rule, the bad news is that I am the only one doing it, it would be nice if others did it.

Michel Drucker: That's why you're here today. Thank you, Doctor. Goodbye, thank you.

Thursday, July 2, 2020

160



This was originally published here, in French (link).
We provide this translation for your convenience. Practical aspects may differ where you live.




The Eclipse is getting longer with the (new) INIs
and LIVE COVID...

By Charles-Edouard!

DTG changes everything... and nothing at the same time


Let's make the hypothesis A that the 'modern' administration, i.e. earlier and with DTG (or BIC), which are at the top of the first-line recommendation, gives a significant possibility to control the virus. Indeed, Hocqueloux has stated, somewhat naively, that to hope to cure one would have to treat earlier, stronger. You and I, we are already in the treatment and, for us, the project of treating earlier does not concern us. It doesn't matter... To test hypothesis A, we take 'modern' patients, in the sense of A, treated early with a second generation INI. We stop the treatment and see if one of the patients controls the virus. And we compare... Compare to what? To the history... That is to say, the period when the treatment was deferred somewhat, and when the first generation INIs did not exist. Nothing better, therefore, as a comparator than Davey's series, which dates from 1999, that is to say 2-3 years after the arrival of triple therapy... My table with the published eclipses is here: Time on the rebound: I finally see you!

&nbspPt.T50
15,4
23,8
38,9
411
547
68,4
79
89,8
95,6
1012
119,8
1211
138
1415
1513
1612
177
187
























Historical values (Davey 1999)


source: jstor.org/stable/121215.
In Davey's series, the presence of an Eclipse at 47 days distorts the mean (11) and standard deviation (9) to the point of suggesting that there are statistically negative values. Removing this exceptionally long Eclipse patient gives a mean of 9.2, a median of 9 and a standard deviation of 3, which is already more reasonable.

With these corrected values, the number of patients with an eclipse of less than 7 d. (6 or less) is 16%. With Davey's calculation, we would find 29%. In clinical intermittence, ICCARRE and Faucy find only 2-3%. For the calculation we use onlinestatbook.

The 'classic' risk is lower than it seems


The first error consists in taking an exceptionally high value (47 days), which is a value to be excluded(outlier). The second is to take a statistical model, of Gauss, which is symmetrical, whereas the Eclipse is not symmetrical: there is no negative Eclipse. When the series is temporal, stochastic, it is appropriate to use a Poisson model. But well... Let's pretend, since what we are interested in is an order of magnitude. It is obvious that a patient with an Eclipse of 3.8 days cannot hope to achieve 1/21... In the classical view, in Davey's time, one can have an appreciation of risk such that even the modest 4/7 shows a statistical risk.

Here is the risk calculated in a very primitive way, without incorporating any risk factors. In 4/7, with Davey's figures, we find 19% of patients at risk of failure. With the corrected figures, we find 2%, and, in the clinic, we find very few (e.g. zero intrinsic failures in ANRS-4D). So the risk is overestimated. Let's say that this error of evaluation, made by many 'specialists', and which ICCARRE denies, is, let's say, forgivable a priori. A Gileaolatre could have used this putative risk to try to block ANRS-4D, a priori. If we look closely, it does not hold, but well... That's the past.

What Davey claims, Leibowitch denies


According to Davey, in whom the shortest Eclipse is 4 days, doing the 5/7 (FOTO - Dr. Cal Cohen) is possible, but in Davey 'Classic', the expected failure rate to do 2/7 'direct' is 25%. Besides, there has not been a Truchis, a Leibo or anyone else to attempt the 2/7'direct'. In light of Davey's dônnées on the Eclipse, the 2/7 (or even 1/7) would be unreasonable. Except that the 2/7 have gone through 3/7, validated: they no longer carry the risk of 3/7... The risk to fail, in progressive method is R(2/7)-R/3/7), that is 25% -21% = 4%; in recalculated Davey risk, it is 5%.

As Leibowitch has shown that it is possible to compensate for a negative event (virological failure) by returning to 7/7 immediately, the risk is doubly minimal; it is less than 5% and the negative consequence of the risk (virological failure) is without prejudice, since we know how to compensate. On a personal level, one could find it bad to fail at 2/7, but then, one would have to make up one's mind...

In practice, Leibo has a much lower failure rate, because it also plays a little on the pharmacokinetic window, by using preferentially and almost exclusively NVP(or at least EFV). In this perspective, the 1/15 is unthinkableThe use of NVP, with the possible exception of a few exceptional cases.

With the New Eclipse everything will change!


With the new Eclipse, this will change, and even more so with the arrival of Islatravir.

Live COVID


Multi-therapy: For the moment the concept remains a bit vague, but this article from Le Collectif Citoyen for FranceSoir (which no one doubts is brilliantly inspired) Covid-19: What is the standard treatment? Does it include hydroxychloroquine? opens a new era: that of a cocktail/care pathway where HCQ would only be an option. The hysteria around HCQ (and the prohibition for pharmacists to dispense it, but not for doctors to prescribe it, yes, yes, this is the French ridiculousness: Liberation: Covid-19: is the dispensing of hydroxychloroquine authorized again?) is such that an alternative must be considered. For myself and my relatives, I will not remain without considering anything.

And to make this strategy my own: 'treat the patients who present themselves as well as possible. That means testing them, assessing the status of those who are positive, and treating them with available therapies. ' ( source Covid-19 - Interview with the man at the heart of the controversy: Didier Raoult)

My available tools: Atazanavir, Doxycycline, Zinc. No PCR, but we can access it if needed, and thus initiate a treatment and interrupt it if the PCR comes back negative. The very vaccine-oriented B. Gates declared that the PCR, if the results are not quick, is useless... Yes, it does to interrupt a treatment taken blindly. I don't really care whether it works or not to the point of recommending it or not, which is not my purpose. I treat, and not with Doliprane!

In the news... As the water flows


La pitie salpetriere publishes its results in 5/7 and 4/7, under INIs, Efficacy of intermittent short cycles of integrase inhibitor-based maintenance in virologically suppressed HIV patients. It works! What did you expect?

The genius of French


I find this video, anachronistic, in the air of time...

Feel free to comment, like, share and use

good weekend, good stuffing and not too many meds ... Huh?

Wednesday, July 1, 2020

159



This was originally published here, in French (link).
We provide this translation for your convenience. Practical aspects may differ where you live.




A New Eclipse has appeared
Followed by LIVE COVID

By Charles-Edouard!

Lescure is the anti-medicine, the anti-science, the anti us: he is our enemy(source), and his delay in publishing the deleterious effects of Remdesivir makes us even more suspicious.

We let JCM comment:

The doctor's concealment of the real causes of the changes in recommendation is amazing.
The problem with Lescure is that he is like Gamelin, he only acts when he is sure, and only attacks when he is in the last line. [...] So, Mr. Lescure, Iccarre or not Iccarre? The problem is that even if Iccarre doesn't work well, when we rather suspect that it does, no one really wants to wait and even less to follow the prudent (and especially prudent for himself) advice of Dr. Lescure.


A New Eclipse has appeared: you had not observed it!


Here is how the case is presented. A new drug appears, more 'powerful' than the others, with opportunities in terms of eradication. So we try... It doesn't eat bread and it keeps you busy. We put a good handful of patients on a promising combo (usually quite strong) and we see if this super-regimen favors PTC: Post-treatment Controllers. With a bit of luck, we may succeed, occasionally, since by treating everyone, without distinction, we also treat the 1% who naturally control. We would not be surprised to find 1 or 2 of them, by chance. There may be such a case here (an experimental treatment may have eliminated HIV in humans, according to doctors), but that is not our topic today. In the study we are interested in, we are not going to find any... Lack of luck, small number of patients... It doesn't matter. The patients take something, we stop, we do the biological follow-up (the PCR... Biological follow-up, there is nothing medical about itwe can do the same thing with mice, bats or pangolins.... No luck (well, yes... it suits the Gileadolatres), it does not work! So the merchants of variety articles and trinkets, at 1000 eu./month, still, are ecstatic: we can't stop the treatment. Unlike the profiteers of the situation, I would like it to work... Don't you? And what I tried, with the infinitesimal hope that it might work, didn't work. Close the bench, the Charles-Edouard's is a lot of bullshit, Fake-News, Public Danger... Quick, let's call Miss Avia and her sulphate machine.

The rebound takes place, relentlessly, but not immediately


Leibowitch never said that the treatment could be stopped. Never... The argument is that the rebound takes place, relentlessly, but not immediately. In a country that has eradicated the virus, one can lift the containment and live in fear of a second wave. Not a great method. We can, alternatively, lift the confinement of the active during the week, to confine the weekends only (Castaner would have loved that against the GJ). There are alternatives to stupid diktats... Second wave or not, everyone sees that the delay to the second wave, gives respite, and that we must take advantage of it!!!. Otherwise, it becomes wearing...

Faucy and Chun back on the rebound and ... The Eclipse


Michael C Sneller, under the supervision of Anthony S Fauci and Tae-Wook Chun publishes Kinetics of plasma HIV rebound in the era of modern antiretroviral therapy.

The conclusion is unwarranted, but the raw data published


The conclusion does not match the body of the article, which is not surprising with Faucy-la-couleuvre, but the data is there, is recent and usable. It has taken years and years to document for 'ethics' committees that analytical interruption is safe and can be used to view/verify/validate any intervention. There has never been any danger, but here it is the American Lacombe/Pialloux/Hydroxychloroquine who are blocking any attempt at a clinical trial. In France, they succeed perfectly since there has never been a single clinical trial in reservoir/remission research. Never.... But in the USA, there are some... And they are legitimate because the US does research on the reservoir and ATIs (Analytical Treatment Interruptions) are considered acceptable there.(In France, the question doesn't even arise, since there is no idea to test). The objective enemies of research, the American Gileadolatres, argue that what was tolerable yesterday, might not be tolerable anymore with the new caviar drugs. It's stupid, but wasting time is a classic tactic.

So Faucy & Co want to show that no, it's the same as always! That's the conclusion they wanted to reach. In order to do this, we need data and we need to publish them, and here, these data enlighten us, once again, about the Eclipse. Now, comparing the Eclipses of the past and the modern ones we see a very important change... To see this, we must take the old and newly published eclipse data...

Well... We'll see it next time...

13/07: The Live COVID resumes


We resume the COVID live, because, there are many things that concern us... In the meantime, Politico has published an interesting opinion: Hydroxychloroquine and remdésivir: small reference points to try to see more clearly in the 'match' of treatments against the coronavirus

07/15: Double co-incidence is evidence


France Soir: Covid-19: hydroxychloroquine works, an irrefutable proof. The argument is simple: Switzerland normally authorizes HCQ (as a reminder, the American FDA acts as an agency for Switzerland, which pays it a share). It's going pretty well. Following @LancetGate (we are still waiting for the trial of the forgers...), Switzerland is infected by the Virus of Prohibition: it bans. 13 days later, the mortality rate (based on solved cases) climbs, climbs. In the meantime, Switzerland reauthorizes, and 13 days later the mortality rate returns to normal.

If you want to avoid dying, you have to take HCQ 13 days before ... (NOT) die... Macron, him, tells us that he would not take it (we don't care... He is the boss at Véran, so discredited...) ... Wait until Brigitte catches it (the virus, not the Macron), you'll see that he'll change his mind quickly... If not, too bad for him...

The genius of French






Feel free to comment, like, share and use

overmedication is an opportunity if you know how to use it!

Wednesday, June 3, 2020

157



This was originally published here, in French (link).
We provide this translation for your convenience. Practical aspects may differ where you live.




Coronavirus, HIV, ARVs, intermittence...(20)


Coronavirus: Settlement of accounts and legal consequences


Graphic update by worldometers and Southern France Morning Post.



06/15/20: Give us back the Chloroquine


To illustrate the stupidity of the organizers of the Recovery (UK) trial, they used the HCQ dose in the indication of amidiasis control. Except that Hydroxycholoroquine is used for amoebiasis. Pr. Perronne declares in France-Soir (decidedly the best media, at the moment) 'I think he confused hydroxychloroquine with hydroxyquinoline.' We're not done laughing. The idea of overdosing, especially in acute treatment, comes from a discussion of pharmacokinetics found here. Now... It is true that in some patients, at Raoult, the dose reached is a little lower than expected and that this is correlated with rare failures. Well... We will see...

The real problem is that here is a molecule that was on the market until the end of January, that has been put on List 2, only to be BANNED in March! It is a total madness. Wait until the airlines get involved... Why them? Because travel prophylaxis are recommendations that are favorable to the development of air traffic. A proof? Remember the Air France International Vaccination Center - 148 rue de l'université 75007 Paris - Travel prophylaxis is of prime interest to airlines.

06/16/20: The black market of hydroxychloroquine

As a user of Plaquenil, on sale over the counter until January 2020(on sale OTC!!!), I didn't even know that it had been put on List 2. This seems very stupid to me, because the traveler's prophylaxis requires to start the prophylactic treatment a few days before departure. If not, you can find some on the spot, but it's not as good, but it's possible. In some areas, the parasite (malaria) has become resistant, so Plaquenil (or Nivaquine) are useless, but not everywhere... In addition, it is not expensive, and the danger to the heart is rare, or even non-existent, or even false, invented from scratch. Palpitations, the patient realizes it, so, frankly...

Get your supplies abroad. You will make a list of countries (many) where chloroquine is sold FREE. And every time you buy it, over the counter, you will shout, with a Marseilles accent: Paris on t'encule! (substitute Paris with whoever you like). And to take up an old slogan: 'molecules so that we fuck each other! Normally, when you come back from your trip, you have to continue the prophylaxis for another 2 months, so you buy this drug, illicit, 'sold in France under the brand name: 'du bon , du bon, Dubonnet'. If you are bothered at the customs, cough strongly, it will calm down the spirits (well... not sure...)

HCQ manufacturers are rubbing their hands. In India, the active ingredient is manufactured by ICPA and Cadila. ICPA's share price has risen from 1150 to 1600 since the beginning of the year, i.e. +40%, which is even better than Gilead. Raoult declares that he has no shares in Gilead or Sanofi, but hey... If I were the boss of ICPA, I would send some pills to IHU. Literally or figuratively? you decide, reader. The Indians, for the moment, it is their only weapon, so they will deploy it, it is normal. Hence Gilead's eagerness to ally with... Mylan...

HCQ to expand the Eclipse. This is not me saying it... But Ananworanitch, who even did a clinical trial, the intervention passed the ethics committees hurdle: so it's legitimate (it's not for ethics to decide if it's legitimate, it's just legitimate to talk about it). I didn't say that it works... I presented, in a conference, at Pasteur, the 3 strategies on the table: Wainberg (DTG pulse), Siliciano (latency inverter), Leibowitch (the Eclipse), and in fact, the fourth one (the Choke and Mute), which I conceptualized, which consists of attacking the Eclipsal cliff. I tried everything independently. The Pulse DTG gave me a phenomenal CV rise, which the latency inverter had failed to prevent. So I'm left with the Choke-and-Mute (1/15, 1/21, under PCR monitoring). But that doesn't mean I'm not interested in the rest. As a principal, no, but as an adjuvant, yes! By the way, I'm going on. What is there to lose?

Toward a ban on dexamethasone? HCQ jurisprudence prevails. If we ban (and even maintain the ban) of HCQ, which works or not, to be debated, then we go straight to the ban of dexamethasone by Macron/Philippe/Véran/Salomon, since the English report an efficiency (in the critical phase of the disease). If it works, it must be banned, that's obvious!

17/06/20: Perronne's book


Perronne's book was published today. Albin Michel has done a lot of work: it's a team effort! (In a word, considering the references, provided, a real work of journalistic verification, which seems to exceed the work of a single author. But well... I am not disappointed. To be disappointed, my expectations would have to be high. This was not the case. It is interesting, lively, in the thick of it.

He tells us about a virologist who would have received up to 500.000 Eu. from the Labs, indicating that fortunately (for him...) he will not mention any name. And my 11,5 Euros, the price of the book, is cat's piss ??? I don't buy a book to be told that such and such a person has touched it without being told who. Because the fact that Gilead is spraying all thePhariseevirology with a fire hose, thank you, we know!

Incidentally, he talks about Garches, about Aids, it's true that the subject of the book is COVID, not HIV, but well... Not a word about the study they published (and then withdrew, we still wonder why, since if they don't publish it, I will). Not a word about the other successes of Garches (ICCARRE, Lyme disease (does it really exist???), Leibowitch death. It seems that the authors have hardly set foot in Garches.

We learn some interesting things, but not much more than reading France-Soir (which is waking up, obviously). I'm at the point of believing that my Live, started very early in the case, is more interesting than the book of Perronne & Co. On the other hand, this book puts in black and white, for eternity, the state of unpreparedness of the 'best health care system in the world'.

The Dallas Buying Club: getting molecules is becoming difficult... We haven't heard the last of this affair, especially since intercontinental travel is not about to resume and this ends up being annoying. The International Post Office is suspended!

18/06/20: False advertising and counter-advertising: what to do?

When you have seen 7 times that BIC is better than DTG (of which it is a copy), that Videx is toxic, that NVP is obsolete, you end up believing it. Lorgeril, who knows a lot about cardiovascular disease, has written a very enlightening post on this point: ' Les inénarrables aventures des graisses saturées en compagnie des maladies cardiovasculaires'. You have identified the deception and you are happy! You won't be caught dead! Yes, you will! Because there is a group effect. You laugh at the toxicity of Videx, like the orthodox Leibowitchians, you are against the current, all happy, but you are marginalized. And since no one takes Videx anymore (except in Spain), Videx disappears and the market imposes itself on you. Fortunately, people in Spain still take Videx... Really??? Yes, BMS sees that sales are stable in Spain. Why is that? Because the whole of Europe has no choice but to go to Spain for supplies: it is the last bastion. This is how a grey, parallel market is set up, neither legal nor illegal. HCQ is the same: you just have to go and buy from where there are still some, especially since there will always be some, since there are authorized indications. The Pharma Giants had rushed to 'donate' HCQ to the US strategic stockpile (the federal government didn't spend a penny...) and here they are with millions of doses of the only thing that works against COVID, but as the FDA didn't find any Lazarus effect to it, they withdrew the temporary authorization, in other words, they banned it!!!! Just like in our country! By imitating us ! Because if France, the home of AHQ/AT, bans it, there is no longer any good reason to keep it as a safety stock. The Americans were afraid that Europe would drain HCQ. Fortunately, Macron/Philippe/Veran understood that it was better to be at ease with the Americans than to worry about the health of the French.

a fabricated toxicity. Here is what the CDC (Atlanta) had to say about it, until recently:

The supposed heart toxicity was fabricated! By whom? By Sanofi, of course! An over-the-counter drug is not reimbursed, but a prescription drug is! And as the century-old market for chloroquine is slowly disappearing (resitance of the parasite). Over the counter you sell it for $1, on prescription you sell it for $3. Of course, you will sell a little less... Sanofi ? A strange silence, don't you think?

19/06/20: HCQ and cardiac risk: an organized hysteria

Hysteria is a widely shared misconception that no one would dare to question until it is written off. The flat earth, the existence of a Jesus, cholesterol, BCG, etc., etc. etc. The idea is spread from book to book, without any verification. One comments on the commentator, who commented on another, etc. It is the man who saw the man who saw the bear. One remembers the false 'testimonies' against the intermittence. So we look for the source of this famous cardiac toxicity of HCQ, from which nobody dies. Here is what the FDA says about it: Hundreds of thousands of patients are treated daily (malaria, lupus, arthritis...), so reported cases, by whom? How many? What is 1 per 10,000, 1 per 100,000, 1 per 1 million?

Oh sure, there is probably an increase in arrhythmia, well... But that's what a lot of drugs do. And this is perhaps where the problem lies: this study Risk ofQT prolongation associated with the use of hydroxychloroquine with or without azithromycin in COVID-19 patients shows that the vast majority of the patients studied were already taking 2 QT prolonging drugs. So for them, unless they stopped, the time to get rid of SARS-CoV-2, they had 2, then 3 then 4 (AT) drugs with Qt prolongation! From there to die... Especially since COVID, from a mortality point of view, is still serious

The risk mounted on a pin: read, without laughing, on the WHO website: 6 April 2020 WHO 'Advice on the use of masks in the context of COVID-19'.
How do you want to make people understand the interest of the mask to people who do not wear underwear!!! Yes, we have no formal proof that a slip or a parachute is useful, while the critical risks are there!?! We are in full delirium!

Why is this interesting? Because HCQ will soon be part of our Anti... Anti-viral...

21/06/20: HIV, Intermittence: Charles-Edouard is back!

When I started talking about SARS-CoV-2, in XXX, I didn't think we would have such an anti-HCQ hysteria. My motivation was to comment on the use of ARVs in this context. ARVs were not retained, and everyone's attention was on COVID. There was no need to talk about anything else. I spoke early on about HCQ/AT dual therapy (known as Raoult's prorocole) and I followed suit. The natural slope followed by Raoult (culture techniques, in vitro trial, small primer trial...) is based on a deep and well argued reflection. I didn't know then that the world would split into 2 groups, the PRO-Raoult and the ANTI-Raoult. Having already used hydroxychloroquine, which I thought in all good faith to be sold FREE, during a trip, I was shocked to see the outburst of nonsense about its supposed danger. This hysteria having reached the top of things, it became impossible to get some, while we all have more or less relatives who, even today, are exposed to a mortal risk. I explored the possible alternatives (Doxycycline with or without ATZ Atazanavir), with 2 subjects of satisfaction: I have some, and it is not forbidden by the disastrous Veran/Salomon decree, so we can get some. I had also supplied Zinc. The course of events could have led one to believe that I had become a Radio Raoult, as one could have believed that I was Radio Leibo. This is not true. Radio Leibo exists, it is the Friends of ICCARRE, Radio Raoult, too, it is France-Soir. Reading France Soir (fed by Raoult and Co) made it unnecessary for me to comment.

Soon a classic HIV post: I have delayed the publication of articles that deal with the history of L'Eclipse, Biktarvy, adjuvant techniques. Publishing an interesting topic in July/August is the best way to make it go unnoticed! So that leaves us the leisure of an HIV article, at the end of June, and we start again in Sept, with Biktarvy (which starts its life of 1/7) and other exciting topics. The COVID soap opera is not over! but HIV is back in its place!

Suggested interactions between HCQ and common ARVs (in progress... 05/05)
Moleculesuspected effect
AbacavirNo corresponding record
EmtricitabineNo corresponding records
LamivudineNo matching records
TenofovirNo matching records
EfavirenzThe risk or severity of QTc prolongation may be increased when hydroxychloroquine is combined with efavirenz.
EtravirineNo corresponding records
NevirapineNevirapine metabolism may be decreased when combined with hydroxychloroquine
RilpivirineRisk or severity of QTc prolongation may be increased when hydroxychloroquine is combined with Rilpivirine
AtazanavirRisk or severity of QTc prolongation may be increased when hydroxychloroquine is combined with Atazanavir
DarunavirNo corresponding records
FosamprenavirNo corresponding records
LopinavirSerum hydroxychloroquine concentration may be increased when combined with lopinavir.
TipranavirTipranavir metabolism may be decreased when combined with hydroxychloroquine
BictegravirNo corresponding records
DolutegravirNo corresponding records
ElvegravirNo matching records
RaltegravirNo matching records
CobicistatNo matching records
RitonavirRitonavir serum concentration may be increased when combined with hydroxychloroquine
MaravirocNo corresponding records
cave canem de rigueur this blog is not medical advice
(especially since medicine has proven to be poor) source: drugbank

Tuesday, June 2, 2020

156



This was originally published here, in French (link).
We provide this translation for your convenience. Practical aspects may differ where you live.




Coronavirus, HIV, ARVs, intermittence...(19)


Coronavirus: Settling of accounts


Graphic update by worldometers and Southern France Morning Post.



10/06/20: Settling of accounts in OK Coral


Why is this case important to us? Simple... In some countries, industrialists engage in pure and simple corruption, with an envelope to whoever makes the decision. In France, public decision-makers rely on 'expert' recommendations, which sometimes even have a real 'liberal' status. This is called conflict of interest: it is not intelligible. In the French context, where the active corruption of public decision-makers is not obvious, the real investment of the industrialist is on the experts. Yes, but here it is... As an average patient or as an advocate for ANRS-4D, OMNIBVS, etc. you don't know who is who. If I'm at an OMNIBVS discussion table, for example, and Molina is there, well... Well, I have my own idea, my own private idea, and I don't express it here or anywhere else. But there are many unknown faces. Who will participate in the vote (of the budget), while I don't participate... It is in the secret of the alcoves.

Leibowitch went to Saint Antoine, to fish, for OMNIBVS. He came back empty-handed. Between the Saint Anthony of the good old days and the Saint Anthony of now, new faces have appeared. Me, in 2018, you put me in a room to present OMNIBVS. There are people, Lescure or Lacombre, perhaps, others, whom I do not know from Eve or Adam, given their marginal contribution to HIV. One day I gave a presentation in a university hospital, I was told that it was very successful, and as proof, there were even people from... At the time I was shocked. If I had known I would not have come, not like this. But how to know?

Raoult published a newsletter where he took the members of the CMIT (Collège d'enseignant en maladies infectieuses), listed their 'declared conflicts of interest'(i.e. the small ones..., because the big contracts are excluded from the field of the obligation of declaration... ) and looks at their 'public contribution' to the lynching of hydroxychloroquine, which had been on the market for more than 50 years, was put on List 2 in January, and was banned in March. He publishes, with Elsevier, Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences. Apparently, there are some who wanted to sack Raoult, but worse punishment than Marseille, they did not find, so he is still there and he goes to the sulphateuse. The article will not disappear, because I will analyze it, publicly. Anyway, the justice system is already on the case. Raoult, bound by the jurisprudence of the Ordre des Médecins(exceptional justice if ever there was one), does not mention any name, but we will make the case go forward!

On this point, don't count on the usual hollers, they are all as rotten (and here I have kept the evidence...)

12/06/20: Christian Perronne: I ACCUSE


Christain Perronne is angry and he lets it be known! He publishes a book with Albin-Michel: Is there a mistake they didn't make? It's amazing. I've read the excerpt and I've already placed an order. Yet I'm sick of this virus! Just think, it's June 12 and HCQ, which was on sale until mid-January, on FREE sale, is always forbidden by this damn government that nobody wants anymore (except Merckel and Niels). Perronne is nevertheless a nice guy, maybe a little too nice, but he will have, by dint of diplomacy, succeeded in imposing ANRS-4D and its sequel, which is not nothing, and not much at the same time and which is the very object of my anger. The problem with ANRS-4D is that it does not go far enough! We need to do 3D, 2D, 1 D, 1/14. Remarks, if Perronne had the c****s to go to the end of things, I don't have a blog to do anymore, I move on to something else and basta. I'll keep the blog going as long as Perronne and the others don't get off their asses more.

He's got other things to worry about, but we... No! None of my readers have complained about COVID... While 7/7, it ruins your kidneys, your bones, your libido, your professional life, it's every day! We will get up from the COVID but the 7/7, it will leave you the aftermath! Delfraissy is Pétain... Perronne is the Italian ally. When Raoult says: 'Delfraissy is Pétain', he is not referring to a disgraced regime, but to the fact of recalling the old 'glories' of a trench warfare to manage the defeat of a Blitzkrieg. There, in one word, if one understands it well, without distorting the meaning, Raoult has hit the nail on the head! Who is guilty? The president? The Prime Minister? The ministers of health? The experts? They did not see it coming...
More serious: some knew. Perronne's book: A fierce, undeniable and worrying testimony.

The medical profession has lost all credibility: the fault of Véran & Co... And to the doctors themselves, because, except for a few loudmouths, we have not seen them defend their profession! Perronne does it, but for one Perronne how many defeatists? Have we seen the pharmacists rise to the occasion for the little Nivaquine, which they dispensed in millions of boxes, before they were forced to believe that it is a deadly, immediate poison.

I pity the parrots who only know how to say 'trust your doctor', because the basic doctor is like everyone else faced with a new question, which has not been explored.

12/06/20: Sartans: to stop or not to stop?


ACE inhibitors (sartans ) Since the virus clings to ACEs, a molecule that comes to sit on the receptor might seem favorable. Sartans would act a bit like Maraviroc (which blocks the CCR5 receptor, which is the pharmaceutical counterpart of the Berlin Patient strategy). Except that... There are 2 possible co-receptors (CCR and X4) and that by using Maraviroc, for example alone, in the presence of X4, there is an enrichment of X4, to the detriment of CCR5. In the end, there is not enough CCR5 for Maraviroc to be effective. In CEAs, there are several types, of which 2 situations are possible: sartans have a favorable effect on the virus or an unfavorable one (or neutral, but well...). There is no evidence to decide this.

I am very angry with these parrots who only know how to repeat over and over again: 'trust your doctor'! Except that the basic doctor doesn't know any more than the average Pekingese, since the suspicion of a possible role for sartans has only been raised in intelligible terms since Raoult made a rich description of COVID. This did not prevent the cardio-therapeutic 'Zotorities' from recommending continued treatment with sartans, without the slightest hint of a problem. They pulled this out of their hat. And, as the industry's mouthpiece, it is hard to see how they could have said anything else. The American Heart Association and the European Heart Association (at the height of corruption) did it early for people who had no documented cases at hand!

Raoult discusses this with precision, in this latest video(Microbiology Staff of 09/06/20 at minute 32) where he says: WE KNOW NOTHING. Faced with an unresolved question, the doctor is no better a fortune teller. When there is no knowledge, there is no knowledge, we have to admit it. Let's imagine that the analysis, which is difficult at the moment, leads to the conclusion that it is the sartans (the 'cure') and not the underlying condition (hypertension) that is THE cause of significant excess mortality among sartan users, well, AHA or ACS will have no other option than to denigrate and quickly forget their risky (and irresponsible, because there is no responsible signatory) position. So, it's all a bunch of hot air.

12/06/20: Sartans and medical corruption


The following is an excerpt from the article Renin-Angiotensin-Aldosterone System Inhibitors and Covid-19

The author endorses the opinion of the AHA and ECA based on an article by Mehra. Mehra ? ... Mehra ?? ... Yes, the same Mehra who published a completely misleading article in the Lancet, and who published this one, again on the basis of figures invented, prestidigitalised, by the sulphurous Surgisphere. This article appeared in the NEJM, and was retracted for the same reasons (falsification of data). But the opinion of the AHA (and ECA) are unchanged!



Supposed interactions between HCQ and common ARVs (in progress... 05/05)
Moleculesuspected effect
AbacavirNo corresponding record
EmtricitabineNo corresponding records
LamivudineNo matching records
TenofovirNo matching records
EfavirenzThe risk or severity of QTc prolongation may be increased when hydroxychloroquine is combined with efavirenz.
EtravirineNo corresponding records
NevirapineNevirapine metabolism may be decreased when combined with hydroxychloroquine
RilpivirineRisk or severity of QTc prolongation may be increased when hydroxychloroquine is combined with Rilpivirine
AtazanavirRisk or severity of QTc prolongation may be increased when hydroxychloroquine is combined with Atazanavir
DarunavirNo corresponding records
FosamprenavirNo corresponding records
LopinavirSerum hydroxychloroquine concentration may be increased when combined with lopinavir.
TipranavirTipranavir metabolism may be decreased when combined with hydroxychloroquine
BictegravirNo corresponding records
DolutegravirNo corresponding records
ElvegravirNo matching records
RaltegravirNo matching records
CobicistatNo matching records
RitonavirRitonavir serum concentration may be increased when combined with hydroxychloroquine
MaravirocNo corresponding records
cave canem de rigueur this blog is not medical advice
(especially since medicine has proven to be poor) source: drugbank